J.P. Morgan Weighs In On Juno Therapeutics Inc. And Celgene Corporation Following Partnership Announcement
July 01, 2015 at 11:19 AM EDT
On June 29, Juno Therapeutics Inc. and Celgene Corporation announced a ten-year collaboration to develop new therapies for cancer and auto-immune diseases, specifically T cell therapies.
